Warmuth Markus

CIK 00018556431 companyBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001855643

Recent Transactions

19 trades

Sale
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-07-16$23.18/sh−9,500→ 585,038 total
Sale
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-06-01$19.41/sh−4,998→ 595,006 total
Sale
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-06-01$19.73/sh−468→ 594,538 total
Sale
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-05-01$18.92/sh−5,467→ 600,004 total
Sale
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-04-14$17.64/sh−8,000→ 605,471 total
Sale
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-03-02$17.92/sh−5,466→ 613,471 total
Sale
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-01-07$23.24/sh−3,707→ 620,696 total
Sale
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-01-07$23.88/sh−1,450→ 619,246 total
Sale
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-01-07$24.57/sh−309→ 618,937 total
Sale
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-01-05$15.17/sh−10,135→ 624,403 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2026-01-02+406,000→ 406,000 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-01-02+90,000→ 634,538 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2025-01-02+128,000→ 544,538 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2025-01-02+575,000→ 575,000 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2024-01-02+346,000→ 346,000 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2023-01-03+472,000→ 472,000 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2022-03-01+315,600→ 315,600 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2021-06-23+141,623→ 141,623 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2021-04-12+538,517→ 538,517 total

Companies

Monte Rosa Therapeutics, Inc.
Director, President & CEO
$GLUE

Recent Filings

Address

MONTE ROSA THERAPEUTICS, INC. 321 HARRISON AVENUE, SUITE 900

BOSTON, MA, 02118

View on SEC.gov